Decision-tree based Next Best Action recommendation brought in 25 new HCPs resulting in $472k incremental revenue within the first month…

Machine learning solution proactively identified look-alike eligible PCSK9 patients for a Big Pharma client unlocking $60M in incremental revenue…

ML-based solution reduced patient drop-offs and discontinuation of therapy by 18% driving $74M incremental annual revenue…

NLP and machine learning combine to open up market opportunity worth $160M by identifying 1k new patients for ultra rare disease Oncology brand…

The Machine Learning Solution predicted likely share and rebate scenarios at a Plan level to enable optimization.

ML solution predicted with 76% accuracy 3k new patients with a high likelihood of being prescribed the target brand, translating to $480M in potential revenue.